Feb 14, 2013 - 9:05 am
Hello EVERYONE----HOPE YOU ARE DOING WELL
WAnted to share a report published on www.medscape .com regarding androgen blockade.
Report was written by Nick Mulcahey --dated February 12,2013
Report states > Long term androgen blockade in men with high risk localized prostrate cancer CAN BE SAFELY reduced from the current standard of 36 months to 18 months without compromising survival, according to results from a phase 3 trial.
The lead study author Abdenour Nabid ,MD associate professor at Centre Hospitalier Universitaire de Sherbrooke in Quebec ,Canada spoke at the American Society of Clinical Oncology being held in advance of the 2013 Genitourinary Cancer Symposium , February 14 to 16 in Orlando Florida. ALL of the men in the study treated with radiotherapy. The study involved at least one of the following risk factors, a prostrate specific antigen (PSA) level above 7 (ALL had node-negative disease)
Wanted to share this info with my friends on this site.